0

    531752

    BIOGEN

    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    BIOGEN PHARMACHEM INDUSTRIES L Share Price Today

    Investment Returns

    Over 1 Month -3.33% Over 3 Months -27.50% Over 6 Months -50.84% Over 1 Year -63.29%
    Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    BIOGEN PHARMACHEM INDUSTRIES L fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 29.50
    • P/E Ratio (TTM) 0.00
    • Beta 0.08
    • Book Value / share 0.94
    • Return on equity 0.00%
    • EPS (TTM) 0.00
    • Dividend yield [-]%
    • Net profit/quarter (Cr) 0.22
    info icon alternate text

    BIOGEN PHARMACHEM INDUSTRIES L Financials

    Open financial information
    Revenue
    Net income
    Particulars JUN 2026 (Values in Cr)
    Revenue 0.00
    Operating Expense 0.22
    Net Profit 0.22
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) 0.02
    EBITDA 0.22
    Effective Tax Rate (%) 0.00
    Particulars MAR 2026 (Values in Cr)
    Revenue 0.00
    Operating Expense 0.94
    Net Profit -0.36
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) 0.00
    EBITDA -0.36
    Effective Tax Rate (%) 0.00
    Particulars DEC 2025 (Values in Cr)
    Revenue 0.00
    Operating Expense 0.08
    Net Profit 0.46
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) 0.01
    EBITDA 0.46
    Effective Tax Rate (%) 0.00
    Particulars SEP 2025 (Values in Cr)
    Revenue 0.00
    Operating Expense 0.39
    Net Profit -0.49
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) -0.01
    EBITDA -0.49
    Effective Tax Rate (%) 0.00
    Particulars JUN 2025 (Values in Cr)
    Revenue 0.00
    Operating Expense 0.20
    Net Profit 1.34
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) 0.01
    EBITDA 1.34
    Effective Tax Rate (%) 0.00
    Particulars MAR 2026 (Values in Cr)
    Revenue 0.00
    Operating Expense 1.60
    Net Profit 0.86
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) 0.01
    EBITDA 0.96
    Effective Tax Rate (%) 10.41
    Particulars MAR 2025 (Values in Cr)
    Revenue 0.00
    Operating Expense 1.13
    Net Profit -0.29
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) 0.00
    EBITDA -0.29
    Effective Tax Rate (%) 0.00
    Particulars MAR 2024 (Values in Cr)
    Revenue 0.00
    Operating Expense 0.45
    Net Profit 1.93
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) 0.03
    EBITDA 1.93
    Effective Tax Rate (%) 0.00
    Particulars MAR 2023 (Values in Cr)
    Revenue 0.00
    Operating Expense 0.46
    Net Profit 0.46
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) 0.00
    EBITDA 0.46
    Effective Tax Rate (%) 0.00
    Particulars MAR 2022 (Values in Cr)
    Revenue 2.47
    Operating Expense 2.18
    Net Profit -0.01
    Net Profit Margin (%) -0.40
    Earnings Per Share (EPS) 0.00
    EBITDA -0.01
    Effective Tax Rate (%) 0.00
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 0.86
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.00
    EBITDA Margin -24.17
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 0.87
    ROE % 2.96
    ROCE % 2.96
    Total Debt to Total Equity 0.00
    EBITDA Margin 81.09
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 0.84
    ROE % -0.34
    ROCE % -0.34
    Total Debt to Total Equity 0.00
    EBITDA Margin -21.98
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 0.83
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.00
    EBITDA Margin -0.40
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 0.83
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.00
    EBITDA Margin -98.77
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 2.01
    Total Assets 92.01
    Total Liabilities 92.01
    Total Equity 91.92
    Share Outstanding 65
    Price to Book Ratio 1.12
    Return on Assets (%) -0.31
    Return on Capital (%) -0.32
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 0.01
    Total Assets 56.82
    Total Liabilities 56.82
    Total Equity 56.52
    Share Outstanding 65
    Price to Book Ratio 1.22
    Return on Assets (%) 3.39
    Return on Capital (%) 3.42
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 0.12
    Total Assets 54.82
    Total Liabilities 54.82
    Total Equity 54.58
    Share Outstanding 65
    Price to Book Ratio 0.70
    Return on Assets (%) 0.83
    Return on Capital (%) 0.83
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 0.08
    Total Assets 54.94
    Total Liabilities 54.94
    Total Equity 54.13
    Share Outstanding 65
    Price to Book Ratio 1.69
    Return on Assets (%) -0.01
    Return on Capital (%) -0.02
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 0.00
    Total Assets 54.25
    Total Liabilities 54.25
    Total Equity 54.14
    Share Outstanding 65
    Price to Book Ratio 0.25
    Return on Assets (%) -2.95
    Return on Capital (%) -2.96
    Particulars MAR 2025 (Values in Cr)
    Net Income -0.29
    Cash from Operations -1.08
    Cash from Investing -32.61
    Cash from Financing 35.70
    Net change in Cash 1.99
    Free Cash Flow -1.08
    Particulars MAR 2024 (Values in Cr)
    Net Income 1.93
    Cash from Operations 1.94
    Cash from Investing -2.05
    Cash from Financing 0.00
    Net change in Cash -0.11
    Free Cash Flow 1.94
    Particulars MAR 2023 (Values in Cr)
    Net Income 0.45
    Cash from Operations 1.70
    Cash from Investing -1.65
    Cash from Financing 0.00
    Net change in Cash 0.04
    Free Cash Flow 1.70
    Particulars MAR 2022 (Values in Cr)
    Net Income 0.00
    Cash from Operations 1.39
    Cash from Investing -1.32
    Cash from Financing 0.00
    Net change in Cash 0.07
    Free Cash Flow 1.39
    Particulars MAR 2021 (Values in Cr)
    Net Income -1.60
    Cash from Operations 3.94
    Cash from Investing -3.63
    Cash from Financing -0.30
    Net change in Cash 0.00
    Free Cash Flow 3.94
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    ALFRED HERBERT (INDIA) LTD. 3163.15 6.62 0.42 243.56 2200.00 3974.00
    BAJAJ HOLDINGS & INVESTMENT LT 11427.10 14.36 1.73 127172.20 8597.50 14753.50
    TATA INVESTMENT CORPORATION LT 667.05 78.29 1.15 33749.59 538.70 1184.00
    Max Financial Services Limited 1524.80 0.00 9.96 52623.10 1408.05 1891.35
    Naperol Investments Limited 1437.10 23.31 0.90 825.90 801.00 2041.00
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    ALFRED HERBERT (INDIA) LTD. 3163.15 0.00 0.43 243.56 2200.00 3974.00
    ARAVALI SECURITIES & FINANCE L 3.90 0.00 -5.34 5.91 3.35 6.54
    BAJAJ HOLDINGS & INVESTMENT LT 11427.10 42.16 4.65 127172.20 8597.50 14753.50
    GKW LIMITED 1629.70 0.00 2.39 972.93 1375.00 1985.40

    BIOGEN PHARMACHEM INDUSTRIES L shareholding pattern

    Holding
    99.99%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    BIOGEN PHARMACHEM INDUSTRIES L Technicals Summary

    0.28 -3.44 redarrow
    red-green-graph indicator
    16 Bearish
    0 Bullish
    • 5 Days 0.30
    • 26 Days 0.30
    • 10 Days 0.30
    • 50 Days 0.30
    • 12 Days 0.30
    • 100 Days 0.40
    • 20 Days 0.30
    • 200 Days 0.50
    0.29 PIVOT
    First Support 0.28 First Resistance 0.30 Second Support 0.27 Second Resistance 0.31 Third Support 0.26 Third Resistance 0.32
    RSI 41.11 ADX 15.66 MACD -0.01 Williams % R -83.33 Commodity Channel Index (CCI) -74.52
    Date 2026-08-06 Week 3553138.00 Same Day 2535404.00 Month 3235512.00
    1 Year 0.08 3 Year 0.50
    Over 1 Month
    -3.33% down
    Over 1 Year
    -63.29% down
    Over 3 Months
    -27.50% down
    Over 3 Years
    -23.97% down
    Over 6 Months
    -50.84% down
    Over 5 Years
    -21.77% down

    BIOGEN PHARMACHEM INDUSTRIES L Corporate Actions

    Ex-Date Ex-Bonus Ratio
    15 May 2026 15 May 2026 1:6
    Ex-Date Old FV NEW FV Record Date
    15 Jul 2003 10.0 1.0 21 Jul 2003

    Top Gainers

    Top Losers

    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Biogen Pharmachem Industries Ltd?

    Answer Field

    Biogen Pharmachem Industries Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 0.28 as on Aug 07 2026 03:30 PM.

    What is the Market Cap of Biogen Pharmachem Industries Ltd Share?

    Answer Field

    The market cap of Biogen Pharmachem Industries Ltd for NSE ₹ 0.00 & for BSE ₹ 29.50 as on Aug 07 2026 03:30 PM.

    What is the 52 Week High and Low of Biogen Pharmachem Industries Ltd?

    Answer Field

    The 52 Week High and Low of Biogen Pharmachem Industries Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 0.81 and ₹ 0.27.

    What is 1 year return for Biogen Pharmachem Industries Ltd?

    Answer Field

    The 1 year returns on the stock has been -63.29%.

    What is the P/E Ratio of Biogen Pharmachem Industries Ltd Share?

    Answer Field

    As on Aug 07 2026 03:30 PM the price-to-earnings (PE) ratio for Biogen Pharmachem Industries Ltd share is 0.00.

    What is the PB ratio of Biogen Pharmachem Industries Ltd Share?

    Answer Field

    As on Aug 07 2026 03:30 PM, the price-to-book (PB) ratio for Biogen Pharmachem Industries Ltd share is 0.94.

    How to Buy Biogen Pharmachem Industries Ltd Share?

    Answer Field

    You can trade in Biogen Pharmachem Industries Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Biogen Pharmachem Industries Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Biogen Pharmachem Industries Ltd shares on the Bajaj Broking app, follow these steps:

    1. Login to the Bajaj Broking App

    2. Click on the Search Icon

    3. Search “Biogen Pharmachem Industries Ltd”

    4. Click on the BUY icon

    5. Place a buy order specifying the desired quantity of shares.

    6. Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |